Peter Rosier

Dr. Peter Rosier

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2002 in Neurourology and Urodynamics
Verified
Journal Article
Closed access
PDF file
PAPaul Abrams
Paul Abrams
LCLinda Cardozo
Linda Cardozo
MFMagnus Fall
Magnus Fall
DGDerek Griffiths
Derek Griffiths
PRPeter Rosier
Peter Rosier
AWAlan Wein
Alan Wein

1 January 2003 in Urology
Verified
Journal Article
Closed access
PAPaul Abrams
Paul Abrams
LCLinda Cardozo
Linda Cardozo
MFMagnus Fall
Magnus Fall
DGDerek Griffiths
Derek Griffiths
PRPeter Rosier
Peter Rosier
AWAlan Wein
Alan Wein

1 July 2002 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
PAPaul Abrams
Paul Abrams
LCLinda Cardozo
Linda Cardozo
MFMagnus Fall
Magnus Fall
DGDerek Griffiths
Derek Griffiths
PRPeter Rosier
Peter Rosier
AWAlan Wein
Alan Wein

5 December 2016 in Neurourology and Urodynamics
Verified
Journal Article
Closed access
PDF file
PRPeter Rosier
Peter Rosier
WSWerner Schaefer
Werner Schaefer
GLGunnar Lose
Gunnar Lose
HGHoward B. Goldman
Howard B. Goldman
MGMichael Guralnick
Michael Guralnick
HHHashim Hashim
Hashim Hashim

14 August 2018 in Neurourology and Urodynamics
Verified
Journal Article
Closed access
PDF file
PAPaul Abrams
Paul Abrams
KAKarl‐Erik Andersson
Karl‐Erik Andersson
AAApostolos Apostolidis
Apostolos Apostolidis
LBLori Birder
Lori Birder
DBDonna Bliss
Donna Bliss
TCThe Members Of The Committees
The Members Of The Committees

1 April 1998 in Brain
Verified
Journal Article
Open access
PDF file
GNG J Nijeholt
G J Nijeholt
MWM A van Walderveen
M A van Walderveen
JCJ A Castelijns
J A Castelijns
JWJ H van Waesberghe
J H van Waesberghe
CPC Polman
C Polman
FBF Barkhof
F Barkhof
We investigated various magnetic resonance MRI parameters for both brain and spinal cord to see if any improved the clinicoradiological correlation in multiple sclerosis. Ninety-one multiple sclerosis patients (28 relapsing-remitting, 32 secondary progressive and 31 primary progressive) were imaged using conventional T1, proton density- and T2-weighted MRI of the brain and spinal cord. Focal brain and spinal cord lesion load was scored, as were diffuse signal abnormalities, brain ventricular volume and spinal cord cross-sectional area. Clinical measures included the expanded disability status scale (EDSS), the functional systems score and a dedicated urology complaint questionnaire. Secondary progressive patients differed from relapsing-remitting and primary progressive patients by a larger number of hypointense T1 lesions in the brain, ventricular enlargement and spinal cord atrophy. Primary progressive patients more often had diffuse abnormalities in the brain and/or spinal cord than did relapsing-remitting and secondary progressive patients. In the entire study population, EDSS correlated with both brain and spinal cord MRI parameters, which were independent. The urological complaint score correlated only with spinal cord MRI parameters. In relapsing-remitting and secondary progressive multiple sclerosis, the correlation between MRI and clinical parameters was better than in the entire population. In this subgroup EDSS variance could be explained best by T1 brain lesion load, ventricle volume and spinal cord cross-sectional area. In the primary progressive subgroup the clinicoradiological correlation was weak for brain parameters but was present between spinal cord symptoms and spinal cord MRI parameters. In conclusion, the different brain and spinal cord MRI parameters currently available revealed considerable heterogeneity between clinical subtypes of multiple sclerosis. In relapsing-remitting and secondary progressive multiple sclerosis both brain and spinal cord MRI may provide a tool for monitoring patients, while in primary progressive multiple sclerosis the clinicoradiological correlation is weak for brain imaging.